日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Safety of DNV3 (a Lymphocyte-activation Gene 3-blocking Antibody) Combined With Toripalimab and Chemotherapy in Advanced Melanoma: An Open-label, Single-arm Clinical Trial

DNV3（一种淋巴细胞活化基因3阻断抗体）联合托瑞普利单抗和化疗治疗晚期黑色素瘤的疗效和安全性：一项开放标签、单臂临床试验

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70648
Lin, Jing; Chen, Lizhu; Chen, Ling; Wang, Dingyi; Lu, Yuping; Zhang, Huishan; Chen, Ping; Yan, Wei; Xiao, Zuoxiang; Chen, Yu
黑色素瘤
细胞生物学
发表日期：2026
文献求助 收藏

Correction: Global assessment of hepatic safety in novel immunotherapies: a systematic review and meta-analysis

更正：新型免疫疗法肝脏安全性的全球评估：系统评价和荟萃分析

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1788767
Ye, Minyan; Dong, Yinuo; Li, Xiaoyun; Zhi, Yang; Lu, Yuping; Tang, Jieting; Zhong, Wei; Lei, Xiaohong; Mao, Yimin; Huang, Sha; Song, Yanyan
免疫/内分泌
发表日期：2026
文献求助 收藏

Clinical characteristics, treatment response, and survival outcomes in melanoma patients with cavity carcinomatosis: A retrospective analysis

黑色素瘤伴腔癌病患者的临床特征、治疗反应和生存结局：一项回顾性分析

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.70254
Lin, Zhongqiao; Zhu, Li; Huang, Yuyang; Chen, Lizhu; Lu, Yuping; Chen, Yu; Lin, Jing
黑色素瘤
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Global assessment of hepatic safety in novel immunotherapies: a systematic review and meta-analysis

新型免疫疗法肝脏安全性的全球评估：系统评价和荟萃分析

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1677998
Ye, Minyan; Dong, Yinuo; Li, Xiaoyun; Zhi, Yang; Lu, Yuping; Tang, Jieting; Zhong, Wei; Lei, Xiaohong; Mao, Yimin; Huang, Sha; Song, Yanyan
免疫/内分泌
发表日期：2025
文献求助 收藏

Identifying microbial proteins and changes in proteome in spontaneously fermented pulse protein isolates.

鉴定自发发酵豆类蛋白分离物中的微生物蛋白和蛋白质组变化

期刊:Food Chemistry Molecular Sciences
影响因子:4.7
doi:10.1016/j.fochms.2025.100254
Das Prem Prakash, Xu Caishuang, Lu Yuping, Liu Enyu, Jafarian Zahra, Tanaka Takuji, Korber Darren, Nickerson Michael, Rajagopalan Nandhakishore
微生物学
发表日期：2025
文献求助 收藏

Erdafitinib suppresses pathological retinal angiogenesis via dual targeting of FGFR and VEGFR2 signaling

Erdafitinib通过双重靶向FGFR和VEGFR2信号通路抑制病理性视网膜血管生成

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-025-20917-7.
Yingli Mo ,Bei Lu ,Yuping Xu ,Xiaojuan Fan ,Qingshuang Zhang ,Shaowu Cheng ,Lu Tang ,Qinghua Peng
信号转导
Angiogenesis
EGF
EGFR
VEGF
血管生成
发表日期：2025
文献求助 收藏

Survival nomogram for melanoma with bone metastasis based on the SEER database and an external validation cohort

基于SEER数据库和外部验证队列的骨转移黑色素瘤生存列线图

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1680191
Lu, Yuping; Chen, Lizhu; Zheng, Shicheng; Zhu, Li; Wu, Zhida; Chen, Yu; Lin, Jing
黑色素瘤
发表日期：2025
文献求助 收藏

Identifying the Most Crucial Factors Influencing Self-Compassion Among Community-Dwelling Older Adults with Type 2 Diabetes Using Interpretable Machine Learning

利用可解释机器学习识别影响社区居住的2型糖尿病老年人自我关怀的最关键因素

期刊:Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
影响因子:3
doi:10.2147/DMSO.S556917
Xu, Junxian; Yang, Jianzhong; Lu, Yuping; Yang, Jieyu; Gu, Chao; Zhu, Jiahuan; Yang, Lanni
糖尿病
代谢
发表日期：2025
文献求助 收藏

Hepatotoxicity of ICI monotherapy or combination therapy in HCC: A systematic review and meta-analysis

免疫检查点抑制剂单药或联合治疗肝细胞癌的肝毒性：系统评价和荟萃分析

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0323023
Lu, Yuping; Lin, Jing; Lu, Yufeng; Lin, Luping; Zheng, Shicheng; Chen, Yu; Huang, Sha
肿瘤
肿瘤免疫
细胞生物学
毒理研究
免疫/内分泌
发表日期：2025
文献求助 收藏

The current status and influencing factors of humanistic care ability among dental specialty nurses: a cross-sectional study

口腔专科护士人文关怀能力现状及影响因素：一项横断面研究

期刊:
影响因子:
doi:10.1186/s12912-025-03932-x
Su, Liqing; Zhang, Yumeng; Zhu, Qingying; Wang, Lijuan; Chang, Jian; Hu, Congxiu; Lu, Yuping; Zhang, Yanhong; Wang, Xiaping; Li, Zhaorong; Chen, Liying; Lin, Shengli
发表日期：2025
文献求助 收藏